CGMP Deviations: Presence of NDMA impurity detected in product.
Drugs Recalls
Prescription and over-the-counter medications
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
CGMP Deviations: Presence of NDMA impurity detected in product.
Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 68151-2584-0.
Sanofi-Aventis U.S.
CGMP Deviations: Presence of NDMA impurity detected in product.
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Regular Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 67751-151-01.
Sanofi-Aventis U.S.
CGMP Deviations: Presence of NDMA impurity detected in product.
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
CGMP Deviations: Presence of NDMA impurity detected in product.
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Regular Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 05269-220-25.
Sanofi-Aventis U.S.
CGMP Deviations: Presence of NDMA impurity detected in product.
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.